Calissio Resources Group Inc (CRGP)

[ntbiotech]

They just sold their main drug to another company for $500 million. $200 mil dividend to be payed out; $150 million debt payment; will be left with $159 million and few drug candidates in early phase trials. I see a squeeze with 31% shorts. Technically the company can also buy shares to get dividend on it. I am thinking if 31% of shares short then company only needs to pay dividend for shares not short. Could increase dividend payment/share.

Dividend announced about 10 days ago.